Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-01T00:12:04.335Z Has data issue: false hasContentIssue false

38 - Cell cycle: mechanisms of control and dysregulation in cancer

from Part 2.5 - Molecular pathways underlying carcinogenesis: cell cycle

Published online by Cambridge University Press:  05 February 2015

Erik S. Knudsen
Affiliation:
Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA
Ryan J. Bourgo
Affiliation:
Kimmel Cancer Center, Department of Cancer Biology, Thomas Jeferson University, Philadelphia, PA, USA
Elizabeth L. Gosnell
Affiliation:
Kimmel Cancer Center, Department of Cancer Biology, Thomas Jeferson University, Philadelphia, PA, USA
Jeffry L. Dean
Affiliation:
Kimmel Cancer Center, Department of Cancer Biology, Thomas Jeferson University, Philadelphia, PA, USA
A. Kathleen McClendon
Affiliation:
Kimmel Cancer Center, Department of Cancer Biology, Thomas Jeferson University, Philadelphia, PA, USA
Edward P. Gelmann
Affiliation:
Columbia University, New York
Charles L. Sawyers
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York
Frank J. Rauscher, III
Affiliation:
The Wistar Institute Cancer Centre, Philadelphia
Get access

Summary

Introduction

The mitotic cell cycle consists of four discrete phases that comprise the ordered processes required for the accurate division and partition of the genetic material into viable daughter cells (Figure 38.1). These processes are tightly controlled by cellular machinery, which not only orchestrates regulation of the various cell-cycle phases, but also integrates environmental cues to ensure that proliferation occurs only when conditions are favorable. The integrity of these processes is of utmost significance, and deregulation of cell-cycle regulatory mechanisms can contribute to tumorigenesis through a variety of discrete mechanisms, as will be discussed.

Mechanisms of G1 control

The majority of cells in adult tissues harbor a diploid (2N) DNA content, and have generally exited from the cell cycle. These cells exist outside the conventional active cell cycle in a phase termed G0. This G0 stage encompasses a variety of biological states, including terminal differentiation, quiescence, and senescence. Upon the engagement of appropriate physiological signals, G0 cells can commit to subsequent mitotic cell division. Typically, this entry into the cell cycle is mediated by an increase in mitogenic signaling and/or the removal of intrinsic barriers to proliferation (1). In the case of complex tissues, this stimulation of proliferation could be part of intrinsic tissue homeostasis (e.g. proliferation in the crypt to maintain epithelial integrity), response to injury (e.g. liver regeneration), or response to hormonal stimuli (e.g. expansion of mammary epithelia during pregnancy). Although it is widely accepted that such signaling leads to a transition from G0 into G1, the first gap phase, the factors that specify the G0-phase are poorly understood. In addition to a handful of molecular markers, one clear distinction between the G0- and G1-phases is the relative metabolic activity of cells. As such, analyses of gene expression has been suggested to differentiate G0 cells from their G1 counterparts, which are engaged in biosynthetic processes for cell division (2). In contrast with the G0 to G1 transition, those events that mediate progression through G1 have been extensively studied and the general processes involved are comparatively well defined.

Type
Chapter
Information
Molecular Oncology
Causes of Cancer and Targets for Treatment
, pp. 452 - 464
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baserga, SJ, Linnenbach, AJ, Malcolm, S, et al. Polyadenylation of a human mitochondrial ribosomal RNA transcript detected by molecular cloning. Gene 1985;35: 305–12.CrossRefGoogle ScholarPubMed
Bravo, R.Genes induced during the G0/G1 transition in mouse fibroblasts. Seminars in Cancer Biology 1990;1:37–46.Google ScholarPubMed
Kato, J, Matsushime, H, Hiebert, SW, Ewen, ME, Sherr, CJ.Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes and Development 1993;7:331–42.Google ScholarPubMed
Meyerson, M, Harlow, E.Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Molecular and Cellular Biology 1994;14:2077–86.CrossRefGoogle ScholarPubMed
Sherr, CJ.D-type cyclins. Trends in Biochemical Sciences 1995;20;187–90.CrossRefGoogle ScholarPubMed
Mittnacht, S.Control of pRB phosphorylation. Current Opinion in Genetic Development 1998;8:21–7.CrossRefGoogle ScholarPubMed
Matsushime, H, Ewen, ME, Strom, DK, et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992;71:323–34.CrossRefGoogle ScholarPubMed
Diehl, JA.Cycling to cancer with cyclin D1. Cancer Biology and Therapy 2002;1;226–31.CrossRefGoogle ScholarPubMed
Sherr, CJ, Roberts, JM.CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development 1999;13:1501–12.CrossRefGoogle ScholarPubMed
Matsushime, H, Roussel, MF, Ashmun, RA, Sherr, CJ.Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991;65:701–13.CrossRefGoogle ScholarPubMed
Diehl, JA.The cyclin D3 knockout: a pound of redundancy with a dash of tissue specificity. Cancer Biology and Therapy 2004;3:162–4.CrossRefGoogle ScholarPubMed
Knudsen, KE, Diehl, JA, Haiman, CA, Knudsen, ES.Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006;25:1620–8.CrossRefGoogle ScholarPubMed
Sicinski, P, Donaher, JL, Parker, SB, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995;82:621–30.CrossRefGoogle ScholarPubMed
Lee, YM, Sicinski, P.Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human. Cell Cycle 2006;5:2110–14.CrossRefGoogle ScholarPubMed
Ciemerych, MA, Sicinski, P.Cell cycle in mouse development. Oncogene 2005;24:2877–98.CrossRefGoogle ScholarPubMed
Klein, EA, Assoian, RK.Transcriptional regulation of the cyclin D1 gene at a glance. Journal of Cell Science 2008;121:3853–7.CrossRefGoogle ScholarPubMed
Brown, JR, Nigh, E, Lee, RJ, et al. Fos family members induce cell cycle entry by activating cyclin D1. Molecular and Cellular Biology 1998;18:5609–19.Google ScholarPubMed
Eeckhoute, J, Carroll, JS, Geistlinger, TR, Torres-Arzayus, MI, Brown, M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes and Development 2006;20:2513–26.CrossRefGoogle ScholarPubMed
Albanese, C, Johnson, J, Watanabe, G, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. Journal of Biological Chemistry 1995;270:23 589–97.CrossRefGoogle ScholarPubMed
Rao, M, Casimiro, MC, Lisanti, MP, et al. Inhibition of cyclin D1 gene transcription by Brg-1. Cell Cycle 2008;7:647–55.CrossRefGoogle ScholarPubMed
Diehl, JA, Cheng, M, Roussel, MF, Sherr, CJ.Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes and Development 1998;12:3499–511.CrossRefGoogle ScholarPubMed
Diehl, JA, Zindy, F, Sherr, CJ.Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes and Development 1997;11:957–72.CrossRefGoogle ScholarPubMed
Agami, R, Bernards, R.Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000;102:55–66.CrossRefGoogle ScholarPubMed
Pontano, LL, Diehl, JA.DNA damage-dependent cyclin D1 proteolysis: GSK3beta holds the smoking gun. Cell Cycle 2009;8:824–7.CrossRefGoogle ScholarPubMed
Pontano, LL, Aggarwal, P, Barbash, O, et al. Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Molecular and Cellular Biology 2008;28:7245–58.CrossRefGoogle ScholarPubMed
Cheng, M, Sexl, V, Sherr, CJ, Roussel, MF.Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proceedings of the National Academy of Sciences USA 1998;95:1091–6.CrossRefGoogle Scholar
Malumbres, M, Barbacid, M.Mammalian cyclin-dependent kinases. Trends in Biochemical Sciences 2005;30:630–41.CrossRefGoogle ScholarPubMed
Xiong, Y, Zhang, H, Beach, D.Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes and Development 1993;7:1572–83.CrossRefGoogle ScholarPubMed
Serrano, M, Hannon, GJ, Beach, D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704–7.CrossRefGoogle ScholarPubMed
Ewen, ME, Sluss, HK, Sherr, CJ, et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993;73:487–97.CrossRefGoogle ScholarPubMed
Harbour, JW, Luo, RX, Dei Santi, A, Postigo, AA, Dean, DC.Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999;98:859–69.CrossRefGoogle ScholarPubMed
Lundberg, AS, Weinberg, RA.Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Molecular and Cellular Biology 1998;18:753–61.CrossRefGoogle ScholarPubMed
Weinberg, RA.The retinoblastoma protein and cell cycle control. Cell 1995;81:323–30.CrossRefGoogle ScholarPubMed
Lukas, J, Bartkova, J, Rohde, M, Strauss, M, Bartek, J.Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Molecular and Cellular Biology 1995;15:2600–11.CrossRefGoogle ScholarPubMed
Lukas, J, Parry, D, Aagaard, L et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995;375:503–6.CrossRefGoogle ScholarPubMed
Bartek, J, Bartkova, J, Lukas, J.The retinoblastoma protein pathway in cell cycle control and cancer. Experimental Cell Research 1997;237:1–6.CrossRefGoogle ScholarPubMed
Lee, WH, Bookstein, R, Hong, F, et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1997;235:1394–9.CrossRefGoogle Scholar
Friend, SH, Bernards, R, Rogelj, S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643–6.CrossRefGoogle ScholarPubMed
Cavenee, WK, Dryja, TP, Phillips, RA, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779–84.CrossRefGoogle ScholarPubMed
Cavenee, WK, Hansen, MF, Nordenskjold, M, et al. Genetic origin of mutations predisposing to retinoblastoma. Science 1985;228:501–3.CrossRefGoogle ScholarPubMed
Cobrinik, D.Pocket proteins and cell cycle control. Oncogene 2005;24:2796–809.CrossRefGoogle ScholarPubMed
Morris, EJ, Dyson, NJ. Retinoblastoma protein partners. Advances in Cancer Research 2001;82:1–54.CrossRefGoogle ScholarPubMed
Knudsen, ES, Knudsen, KE.Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Experimental Biology and Medicine (Maywood) 2006;231:1271–81.CrossRefGoogle ScholarPubMed
Burkhart, DL, Sage, J.Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Reviews Cancer 2008;8:671–82.CrossRefGoogle ScholarPubMed
Blais, A, Dynlacht, BD.Hitting their targets: an emerging picture of E2F and cell cycle control. Current Opinion in Genetic Development 2004;14:527–32.CrossRefGoogle ScholarPubMed
Blais, A, Dynlacht, BDE2F-associated chromatin modifiers and cell cycle control. Current Opinion in Cell Biology 2007;19:658–62.CrossRefGoogle ScholarPubMed
Dimova, DK, Dyson, NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005;24:2810–26.CrossRefGoogle ScholarPubMed
Nevins, JR.The Rb/E2F pathway and cancer. Human Molecular Genetics 2001;10:699–703.CrossRefGoogle ScholarPubMed
Ren, B, Cam, H, Takahashi, Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes and Development 2002;16:245–56.CrossRefGoogle Scholar
Ishida, S, Huang, E, Zuzan, H, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Molecular and Cellular Biology 2001;21:4684–99.CrossRefGoogle ScholarPubMed
Black, EP, Huang, E, Dressman, H, et al. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Research 2003;63:3716–23.Google ScholarPubMed
Markey, MP, Bergseid, J, Bosco, EE, et al. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene 2007;26:6307–18.CrossRefGoogle ScholarPubMed
Tikoo, R, Zanazzi, G, Shiffman, D, Salzer, J, Chao, MV.Cell cycle control of Schwann cell proliferation: role of cyclin-dependent kinase-2. Journal Neuroscience 2000;20:4627–34.CrossRefGoogle ScholarPubMed
Bracken, AP, Ciro, M, Cocito, A, Helin, K.E2F target genes: unraveling the biology. Trends in Biochemical Sciences 2004;29:409–17.CrossRefGoogle ScholarPubMed
Ohtani, K, DeGregori, J, Nevins, JR.Regulation of the cyclin E gene by transcription factor E2F1. Proceedings of the National Academy of Sciences USA 1995;92:12 146–50.CrossRefGoogle ScholarPubMed
Braden, WA, McClendon, AK, Knudsen, ES.Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. Oncogene 2008;27:7083–93.CrossRefGoogle ScholarPubMed
Angus, SP, Fribourg, AF, Markey, MP, et al. Active RB elicits late G1/S inhibition. Experimental Cell Research 2002;276:201–13.CrossRefGoogle ScholarPubMed
Strobeck, MW, Fribourg, AF, Puga, A, Knudsen, ES.Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 2000;19:1857–67.CrossRefGoogle ScholarPubMed
Hochegger, H, Takeda, S, Hunt, T.Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nature Reviews Molecular and Cellular Biology 2008;9:910–16.CrossRefGoogle ScholarPubMed
Malumbres, M, Barbacid, M.Cell cycle, CDKs and cancer: a changing paradigm. Nature Reviews Cancer 2009;9:153–66.CrossRefGoogle ScholarPubMed
Gu, Y, Rosenblatt, J, Morgan, DO.Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO Journal 2009;11:3995–4005.Google Scholar
Chen, X, Prywes, R. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Molecular and Cellular Biology 1999;19:4695–702.CrossRefGoogle ScholarPubMed
Reed, SI, Bailly, E, Dulic, V, et al. G1 control in mammalian cells. Journal of Cell Science Supplement 1994;18:69–73.CrossRefGoogle ScholarPubMed
Roberts, JM, Koff, A, Polyak, K, et al. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symposia on Quantitative Biology 1994;59:31–8.CrossRefGoogle ScholarPubMed
el-Deiry, WS, Tokino, T, Velculescu, VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817–25.CrossRefGoogle ScholarPubMed
Resnitzky, D, Gossen, M, Bujard, H, Reed, SI.Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Molecular and Cellular Biology 1994;14:1669–79.CrossRefGoogle Scholar
Barriere, C, Santamaria, D, Cerqueira, A, et al. Mice thrive without Cdk4 and Cdk2. Molecular Oncology 2007;1:72–83.CrossRefGoogle ScholarPubMed
Doonan, JH, Kitsios, G.Functional evolution of cyclin-dependent kinases. Molecular Biotechnology 2009;42:14–29.CrossRefGoogle ScholarPubMed
Kozar, K, Ciemerych, MA, Rebel, VI, et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004;118:477–91.CrossRefGoogle ScholarPubMed
Malumbres, M, Sotillo, R, Santamaria, D, et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004;118:493–504.CrossRefGoogle ScholarPubMed
Sherr, CJ, Roberts, JM.Living with or without cyclins and cyclin-dependent kinases. Genes and Development 2004;18:2699–711.CrossRefGoogle ScholarPubMed
Ohtsubo, M, Theodoras, AM, Schumacher, J, Roberts, JM, Pagano, M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Molecular and Cellular Biology 1995;15:2612–24.CrossRefGoogle ScholarPubMed
Fukasawa, K.P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochimica et Biophysica Acta 2008;1786:15–23.Google ScholarPubMed
Knoblich, JA, Sauer, K, Jones, L, et al. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 1994;77:107–20.CrossRefGoogle ScholarPubMed
Mailand, N, Diffley, JF.CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 2007;122:915–26.CrossRefGoogle Scholar
Horowitz, JM, Park, SH, Bogenmann, E, et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proceedings of the National Academy of Sciences USA 1990;87:2775–9.CrossRefGoogle ScholarPubMed
Kaye, FJ.RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908–14.CrossRefGoogle ScholarPubMed
Arnold, A, Papanikolaou, A. Cyclin D1 in breast cancer pathogenesis. Journal of Clinical Oncology 2005;23:4215–24.CrossRefGoogle ScholarPubMed
Palmero, I, Peters, G.Perturbation of cell cycle regulators in human cancer. Cancer Surveys 1996;27:351–67.Google ScholarPubMed
Benzeno, S, Lu, F, Guo, M, et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006;25:6291–303.CrossRefGoogle ScholarPubMed
Knudsen, ES, Knudsen, KE. Tailoring to RB: tumour suppressor status and therapeutic response. Nature Reviews Cancer 2008;8:714–24.CrossRefGoogle ScholarPubMed
Malumbres, M, Barbacid, M.To cycle or not to cycle: a critical decision in cancer. Nature Reviews Cancer 2001;1:222–31.CrossRefGoogle ScholarPubMed
Gartel, AL.p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors 2009;35:161–4.CrossRefGoogle ScholarPubMed
Huang, LW, Chao, SL, Hwang, JL, Chou, YY. Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecologic Oncology 2002;85:524–8.CrossRefGoogle ScholarPubMed
Thomas, GV, Szigeti, K, Murphy, M, et al. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. American Journal of Pathology 1998;153:681–7.CrossRefGoogle ScholarPubMed
Solomon, DA, Kim, JS, Jenkins, S, et al. Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Research 2008;68:2564–9.CrossRefGoogle ScholarPubMed
van Veelen, W, Klompmaker, R, Gloerich, M, et al. P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development. International Journal of Cancer 2009;124:339–45.CrossRefGoogle ScholarPubMed
Ortega, S, Malumbres, M, Barbacid, M.Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochimica et Biophysica Acta 2002;1602:73–87.Google ScholarPubMed
Wolfel, T, Hauer, M, Schneider, J, et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995;269:1281–4.CrossRefGoogle Scholar
Porter, DC, Keyomarsi, K. Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Research 2000;28: E101.CrossRefGoogle ScholarPubMed
Wingate, H, Puskas, A, Duong, M, et al. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 2009;8:1062–8.CrossRefGoogle ScholarPubMed
Milne, AN, Carvalho, R, Jansen, M, et al. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival. Journal of Clinical Pathology 2008;61:311–16.CrossRefGoogle ScholarPubMed
Akli, S, Van Pelt, CS, Bui, T, et al. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Research 2007 67:7212–22.CrossRefGoogle ScholarPubMed
Bortner, DM, Rosenberg, MP.Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Molecular and Cellular Biology 1997;17:453–9.CrossRefGoogle ScholarPubMed
Bell, SP, Dutta, A.DNA replication in eukaryotic cells. Annual Review of Biochemistry 2002;71:333–74.CrossRefGoogle ScholarPubMed
Sclafani, RA, Holzen, TM. Cell cycle regulation of DNA replication. Annual Review of Genetics 2007;41:237–80.CrossRefGoogle ScholarPubMed
Loeb, LA, Monnat, RJ, Jr. DNA polymerases and human disease. Nature Reviews Genetics 2008;9:594–604.CrossRefGoogle ScholarPubMed
Markey, MP, Angus, SP, Strobeck, MW, et al. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Research 2002;62: 6587–97.Google ScholarPubMed
Bell, SP, Stillman, B.ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature 1992;357:128–34.CrossRefGoogle ScholarPubMed
Chesnokov, IN.Multiple functions of the origin recognition complex. International Review of Cytology 2007;256:69–109.CrossRefGoogle ScholarPubMed
Lau, E, Tsuji, T, Guo, L, Lu, SH, Jiang, W.The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB Journal 2007;21:3786–94.CrossRefGoogle ScholarPubMed
Remus, D, Diffley, JF.Eukaryotic DNA replication control: lock and load, then fire. Current Opinion in Cell Biology 2009;21:771–7.CrossRefGoogle ScholarPubMed
Tye, BK.MCM proteins in DNA replication. Annual Review of Biochemistry 1999;68:649–86.CrossRefGoogle ScholarPubMed
Maiorano, D, Lutzmann, M, Mechali, M.MCM proteins and DNA replication. Current Opinion in Cell Biology 2006;18:130–6.CrossRefGoogle ScholarPubMed
Geng, Y, Lee, YM, Welcker, M, et al. Kinase-independent function of cyclin E. Molecular Cell 2007;25:127–39.CrossRefGoogle ScholarPubMed
Sawyer, SL, Cheng, IH, Chai, W, Tye, BK.Mcm10 and Cdc45 cooperate in origin activation in Saccharomyces cerevisiae. Journal of Molecular Biology 2004;340:195–202.CrossRefGoogle ScholarPubMed
Burgers, PM.Polymerase dynamics at the eukaryotic DNA replication fork. Journal of Biological Chemistry 2009;284:4041–5.CrossRefGoogle ScholarPubMed
Zhang, G, Gibbs, E, Kelman, Z, O’Donnell, M, Hurwitz, J.Studies on the interactions between human replication factor C and human proliferating cell nuclear antigen. Proceedings of the National Academy of Sciences USA 1999;96:1869–74.CrossRefGoogle ScholarPubMed
Pursell, ZF, Isoz, I, Lundstrom, EB, Johansson, E, Kunkel, TA.Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 2007;317:127–30.CrossRefGoogle ScholarPubMed
Nick McElhinny, SA, Gordenin, DA, Stith, CM, Burgers, PM, Kunkel, TA. Division of labor at the eukaryotic replication fork. Molecular Cell 2008;30:137–44.CrossRefGoogle ScholarPubMed
Ayyagari, R, Gomes, XV, Gordenin, DA, Burgers, PM. Okazaki fragment maturation in yeast. I. Distribution of functions between FEN1 AND DNA2. Journal of Biological Chemistry 2003;278:1618–25.CrossRefGoogle ScholarPubMed
Kao, HI, Bambara, RA. The protein components and mechanism of eukaryotic Okazaki fragment maturation. Critical Reviews in Biochemistry and Molecular Biology 2003;38 433–52.Google ScholarPubMed
McCulloch, SD, Kunkel, TA.The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Research 2008;18:148–61.CrossRefGoogle ScholarPubMed
Segurado, M, Tercero, JA.The S-phase checkpoint: targeting the replication fork. Biology of the Cell 2009;101:617–27.CrossRefGoogle ScholarPubMed
Kannouche, PL, Lehmann, AR.Ubiquitination of PCNA and the polymerase switch in human cells. Cell Cycle 2004;3:1011–13.CrossRefGoogle ScholarPubMed
Kannouche, PL, Wing, J, Lehmann, AR.Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Molecular Cell 2004;14:491–500.CrossRefGoogle ScholarPubMed
Davis, RK, Chellappan, S.Disrupting the Rb-Raf-1 interaction: a potential therapeutic target for cancer. Drug News and Perspectives 2008;21:331–5.CrossRefGoogle ScholarPubMed
Kawamoto, T, Araki, K, Sonoda, E, et al. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Molecular Cell 2005;20:793–9.CrossRefGoogle ScholarPubMed
Ogi, T, Lehmann, AR.The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair. Nature Cell Biology 2006;8:640–2.CrossRefGoogle ScholarPubMed
Prasad, R, Longley, MJ, Sharief, FS, et al. Human DNA polymerase theta possesses 5ʹ-dRP lyase activity and functions in single-nucleotide base excision repair in vitro. Nucleic Acids Research 2009;37:1868–77.CrossRefGoogle ScholarPubMed
Paulovich, AG, Hartwell, LH.A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 1995;82:841–7.CrossRefGoogle Scholar
Lucca, C, Vanoli, F, Cotta-Ramusino, C, et al. Checkpoint-mediated control of replisome-fork association and signalling in response to replication pausing. Oncogene 2004;23:1206–13.CrossRefGoogle ScholarPubMed
Branzei, D, Foiani, M.Regulation of DNA repair throughout the cell cycle. Nature Reviews Molecular and Cellular Biology 2008;9:297–308.CrossRefGoogle ScholarPubMed
Sogo, JM, Lopes, M, Foiani, M.Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 2002;297:599–602.CrossRefGoogle ScholarPubMed
Byun, TS, Pacek, M, Yee, MC, Walter, JC, Cimprich, KA. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes and Development 2005;19:1040–52.CrossRefGoogle ScholarPubMed
Kohn, KW, Aladjem, MI, Weinstein, JN, Pommier, Y. Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis. Cell Cycle 2009;8:2281–99.CrossRefGoogle ScholarPubMed
Dart, DA, Adams, KE, Akerman, I, Lakin, ND.Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase. Journal of Biological Chemistry 2004;279:16 433–40.CrossRefGoogle ScholarPubMed
Zhu, Y, Alvarez, C, Doll, R, et al. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Molecular and Cellular Biology 2004;24:6268–77.CrossRefGoogle ScholarPubMed
Petersen, BO, Lukas, J, Sorensen, CS, Bartek, J, Helin, K.Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO Journal 1999;18:396–410.CrossRefGoogle ScholarPubMed
Mendez, J, Stillman, B.Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Molecular and Cellular Biology 2000;20:8602–12.CrossRefGoogle ScholarPubMed
Petersen, BO, Wagener, C, Marinoni, F, et al. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes and Development 2000;14:2330–43.CrossRefGoogle ScholarPubMed
Borlado, LR, Mendez, J.CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 2008:29:237–43.CrossRefGoogle ScholarPubMed
Aggarwal, P, Lessie, MD, Lin, DI, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes and Development 2007;21:2908–22.CrossRefGoogle Scholar
Sugimoto, N, Tatsumi, Y, Tsurumi, T, et al. Cdt1 phosphorylation by cyclin A-dependent kinases negatively regulates its function without affecting geminin binding. Journal of Biological Chemistry 2004;279:19 691–7.CrossRefGoogle ScholarPubMed
Liu, E, Li, X, Yan, F, Zhao, Q, Wu, X.Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. Journal of Biological Chemistry 2004;279:17 283–8.CrossRefGoogle ScholarPubMed
Fujita, M.Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells. Cell Division 2006;1:22.CrossRefGoogle ScholarPubMed
Xouri, G, Dimaki, M, Bastiaens, PI, Lygerou, Z.Cdt1 interactions in the licensing process: a model for dynamic spatiotemporal control of licensing. Cell Cycle 2007;6:1549–52.CrossRefGoogle ScholarPubMed
Wang, R, Zhang, JH, Li, Y, et al. [The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population]. Zhonghua Yi Xue Za Zhi 2003;83:1089–92.Google Scholar
Hu, J, McCall, CM, Ohta, T, Xiong, Y.Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nature Cell Biology 2004;6:1003–9.CrossRefGoogle ScholarPubMed
Senga, T, Sivaprasad, U, Zhu, W, et al. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. Journal of Biological Chemistry 2006;281:6246–52.CrossRefGoogle ScholarPubMed
Li, X, Zhao, Q, Liao, R, Sun, P, Wu, X.The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. Journal of Biological Chemistry 2003;278:30 854–8.CrossRefGoogle ScholarPubMed
Yoshida, K, Inoue, I.Regulation of Geminin and Cdt1 expression by E2F transcription factors. Oncogene 2004;23:3802–12.CrossRefGoogle ScholarPubMed
Tada, S, Li, A, Maiorano, D, Mechali, M, Blow, JJ. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nature Cell Biology 2001;3:107–13.CrossRefGoogle ScholarPubMed
Tatsumi, Y, Sugimoto, N, Yugawa, T, et al. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. Journal of Cell Science 2006;119:3128–40.CrossRefGoogle ScholarPubMed
Vaziri, C, Saxena, S, Jeon, Y, et al. A p53-dependent checkpoint pathway prevents rereplication. Molecular Cell 2003;11:997–1008.CrossRefGoogle ScholarPubMed
Karakaidos, P, Taraviras, S, Vassiliou, LV, et al. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability–evidence of E2F-1 transcriptional control over hCdt1. American Journal of Pathology 2004;165:1351–65.CrossRefGoogle ScholarPubMed
Zhu, W, Chen, Y, Dutta, A. Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint. Molecular and Cellular Biology 2004;24:7140–50.CrossRefGoogle ScholarPubMed
Melixetian, M, Ballabeni, A, Masiero, L, et al. Loss of Geminin induces rereplication in the presence of functional p53. Journal of Cell Biology 204;165:473–82.
Saxena, S, Dutta, A.Geminin-Cdt1 balance is critical for genetic stability. Mutation Research 2005;569:111–21.CrossRefGoogle ScholarPubMed
Seo, J, Chung, YS, Sharma, GG, et al. Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. Oncogene 2005;24:8176–86.CrossRefGoogle ScholarPubMed
Gonzalez, S, Klatt, P, Delgado, S, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006;440:702–6.CrossRefGoogle ScholarPubMed
Arentson, E, Faloon, P, Seo, J, et al. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 2002;21;1150–8.CrossRefGoogle ScholarPubMed
Blow, JJ, Gillespie, PJ.Replication licensing and cancer–a fatal entanglement? Nature Reviews Cancer 2008;8:799–806.CrossRefGoogle ScholarPubMed
Williams, GH, Romanowski, P, Morris, L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proceedings of the National Academy of Sciences USA 1998;95:14 932–7.CrossRefGoogle ScholarPubMed
Murphy, N, Millar, E, Lee, CS. Gene expression profiling in breast cancer: towards individualising patient management. Pathology 2005;37:271–7.CrossRefGoogle ScholarPubMed
Ohta, S, Koide, M, Tokuyama, T, et al. Cdc6 expression as a marker of proliferative activity in brain tumors. Oncology Reports 2001;8:1063–6.Google ScholarPubMed
Bravou, V, Nishitani, H, Song, SY, Taraviras, S, Varakis, J.Expression of the licensing factors, Cdt1 and Geminin, in human colon cancer. International Journal of Oncology 2005;27:1511–18.Google ScholarPubMed
Going, JJ, Keith, WN, Neilson, L, et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 2002;50:373–7.CrossRefGoogle ScholarPubMed
Shetty, A, Loddo, M, Fanshawe, T, et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. British Journal of Cancer 2005;93:1295–300.CrossRefGoogle ScholarPubMed
Williams, GH, Stoeber, K.Cell cycle markers in clinical oncology. Current Opinion in Cell Biology 2007;19:672–9.CrossRefGoogle ScholarPubMed
Goldsby, RE, Lawrence, NA, Hays, LE, et al. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nature Medicine 2001;7:638–9.CrossRefGoogle ScholarPubMed
Venkatesan, RN, Treuting, PM, Fuller, ED, et al. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Molecular and Cellular Biology 2007;27:7669–82.CrossRefGoogle ScholarPubMed
Lin, Q, Clark, AB, McCulloch, SD, et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Research 2006;66:87–94.CrossRefGoogle ScholarPubMed
Lukas, C, Sorensen, CS, Kramer, E, et al. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 1999;401:815–18.Google ScholarPubMed
Bassermann, F, Peschel, C, Duyster, J.Mitotic entry: a matter of oscillating destruction. Cell Cycle 2005;4:1515–17.CrossRefGoogle ScholarPubMed
Sullivan, M, Morgan, DO.Finishing mitosis, one step at a time. Nature Reviews Molecular and Cellular Biology 2007;8:894–903.CrossRefGoogle ScholarPubMed
Parker, LL, Sylvestre, PJ, Byrnes, MJ, 3rd, Liu, F, Piwnica-Worms, H.Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells. Proceedings of the National Academy of Sciences USA 1995;92:9638–42.CrossRefGoogle ScholarPubMed
Watanabe, N, Arai, H, Nishihara, Y, et al. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proceedings of the National Academy of Sciences USA 2004;101:4419–24.CrossRefGoogle ScholarPubMed
Mitra, J, Enders, GHCyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 2004;23:3361–7.CrossRefGoogle ScholarPubMed
Lobrich, M, Jeggo, PA.The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nature Reviews Cancer 2007;7:861–9.CrossRefGoogle ScholarPubMed
Crasta, K, Lim, HH, Giddings, TH, Jr., Winey, M, Surana, U. Inactivation of Cdh1 by synergistic action of Cdk1 and polo kinase is necessary for proper assembly of the mitotic spindle. Nature Cell Biology 2008;10:665–75.CrossRefGoogle ScholarPubMed
Chang, DC, Xu, N, Luo, KQ. Degradation of cyclin B is required for the onset of anaphase in mammalian cells. Journal of Biological Chemistry 2003;278:37 865–73.CrossRefGoogle ScholarPubMed
Kramer, ER, Scheuringer, N, Podtelejnikov, AV, Mann, M, Peters, JM. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Molecular Biology of the Cell 2000;11:1555–69.CrossRefGoogle ScholarPubMed
Fang, G, Yu, H, Kirschner, MW.Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Molecular Cell 1998;2:163–71.CrossRefGoogle ScholarPubMed
Kramer, ER, Gieffers, C, Holzl, G, Hengstschlager, M, Peters, JM.Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Current Biology 1998;8:1207–10.CrossRefGoogle ScholarPubMed
Visintin, R, Prinz, S, Amon, A.CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 1997;278:460–3.CrossRefGoogle ScholarPubMed
Zachariae, W, Schwab, M, Nasmyth, K, Seufert, W.Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science 1998;282:1721–4.CrossRefGoogle ScholarPubMed
Kimura, K, Hirano, M, Kobayashi, R, Hirano, T.Phosphorylation and activation of 13S condensin by Cdc2 in vitro. Science 1998;282:487–90.CrossRefGoogle ScholarPubMed
Guttinger, S, Laurell, E, Kutay, U.Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nature Reviews Molecular and Cellular Biology 2009;10:178–91.CrossRefGoogle ScholarPubMed
Izawa, I, Inagaki, M.Regulatory mechanisms and functions of intermediate filaments: a study using site- and phosphorylation state-specific antibodies. Cancer Science 2006;97:167–74.CrossRefGoogle ScholarPubMed
Lindqvist, A, van Zon, W, Karlsson Rosenthal, C, Wolthuis, RM.Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biology 2007;5:e123.CrossRefGoogle ScholarPubMed
DeLuca, JG.Spindle microtubules: getting attached at both ends. Current Biology 2007;17:R966–9.CrossRefGoogle Scholar
Rieder, CL, Salmon, ED.The vertebrate cell kinetochore and its roles during mitosis. Trends in Cell Biology 1998;8:310–18.CrossRefGoogle ScholarPubMed
Cheeseman, IM, Desai, A.Molecular architecture of the kinetochore-microtubule interface. Nature Reviews Molecular and Cellular Biology 2008;9:33–46.CrossRefGoogle ScholarPubMed
Katayama, H, Sasai, K, Kloc, M, Brinkley, BR, Sen, S.Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells. Cell Cycle 2008;7:2691–704.CrossRefGoogle ScholarPubMed
Murata-Hori, M, Wang, YL.The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Current Biology 2002;12:894–9.CrossRefGoogle ScholarPubMed
Peters, JM.The anaphase-promoting complex: proteolysis in mitosis and beyond. Molecular Cell 2002;9:931–43.CrossRefGoogle ScholarPubMed
O’Connell, CB, Khodjakov, AL.Cooperative mechanisms of mitotic spindle formation. Journal of Cell Science 2007;120:1717–22.CrossRefGoogle ScholarPubMed
Musacchio, A, Salmon, ED.The spindle-assembly checkpoint in space and time. Nature Reviews Molecular and Cellular Biology 2007;8:379–93.CrossRefGoogle ScholarPubMed
Wolf, F, Wandke, C, Isenberg, N, Geley, S. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO Journal 2006;25:2802–13.CrossRefGoogle ScholarPubMed
Buonomo, SB, Clyne, RK, Fuchs, J, et al. Disjunction of homologous chromosomes in meiosis I depends on proteolytic cleavage of the meiotic cohesin Rec8 by separin. Cell 2000;103:387–98.CrossRefGoogle ScholarPubMed
Uhlmann, F, Wernic, D, Poupart, MA, Koonin, EV, Nasmyth, K.Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 2000;103:375–86.CrossRefGoogle Scholar
Uhlmann, F.The mechanism of sister chromatid cohesion. Experimental Cell Research 2004;296:80–5.CrossRefGoogle ScholarPubMed
Dumont, S, Mitchison, TJ. Force and length in the mitotic spindle. Current Biology 2009;19:R749–61.CrossRefGoogle ScholarPubMed
Dephoure, N, Zhou, C, Villen, J, et al. A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Sciences USA 2008;105:10 762–7.CrossRefGoogle ScholarPubMed
Bollen, M, Gerlich, DW, Lesage, B.Mitotic phosphatases: from entry guards to exit guides. Trends in Cell Biology 2009;19:531–41.CrossRefGoogle ScholarPubMed
Broceno, C, Wilkie, S, Mittnacht, S.RB activation defect in tumor cell lines. Proceedings of the National Academy of Sciences USA 2002;99:14 200–5.CrossRefGoogle ScholarPubMed
Vietri, M, Bianchi, M, Ludlow, JW, Mittnacht, S, Villa-Moruzzi, E. Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb. Cancer Cell International 2006;6:3.CrossRefGoogle ScholarPubMed
Tamrakar, S, Rubin, E, Ludlow, JW. Role of pRB dephosphorylation in cell cycle regulation. Frontiers in Bioscience 2000;5:D121–37.CrossRefGoogle ScholarPubMed
Dong, Y, Sui, L, Watanabe, Y, Sugimoto, K, Tokuda, M.Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Letters; 177:13–19.CrossRef
Soria, JC, Jang, SJ, Khuri, FR, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Research 2000;60:4000–4.Google ScholarPubMed
Wang, A, Yoshimi, N, Ino, N, Tanaka, T, Mori, H.Overexpression of cyclin B1 in human colorectal cancers. Journal of Cancer Research and Clinical Oncology 1997;123:124–7.CrossRefGoogle ScholarPubMed
Hirao, A, Cheung, A, Duncan, G, et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Molecular and Cellular Biology 2002;22:6521–32.CrossRefGoogle ScholarPubMed
Bartek, J, Lukas, J.Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003;3:421–9.CrossRefGoogle ScholarPubMed
Michel, LS, Liberal, V, Chatterjee, A, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001;409:355–9.CrossRefGoogle ScholarPubMed
Sotillo, R, Hernando, E, Diaz-Rodriguez, E, et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007;11:9–23.CrossRefGoogle ScholarPubMed
Baker, DJ, Jin, F, Jeganathan, KB, van Deursen, JM.Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009;16:475–86.CrossRefGoogle ScholarPubMed
Li, M, Fang, X, Wei, Z, York, JP, Zhang, P.Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. Journal of Cell Biology 2009;185:983–94.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×